Schizophrenia, Psychosis Musculoskeletal Diseases Schizophrenia
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1. A current persecutory delusion as defined by Freeman and Garety (2000) 2. Scoring at least 3 on the conviction scale of the PSYRATS (Haddock et al., 1999) 3. That the delusion has persisted for at least three months; a clinical diagnosis of schizophrenia, schizoaffective disorder or delusional disorder (i.e. a diagnosis of non-affective psychosis (F2) in the International Classification of Diseases and Diagnostic and Statistical Manual IV) 4. Negative beliefs about the self (as indicated by endorsing at least one negative schematic belief on the Brief Core Schema Scale (Fowler et al., 2006)) 5. Aged between 18 and 70 6. Where major changes in medication are being made, entry to the study would not occur until at least a month after stabilisation of dosage 7. Male & female participants
Exclusion criteria
Exclusion criteria: 1. A primary diagnosis of alcohol or substance dependency 2. Organic syndrome or learning disability 3. A command of spoken English inadequate for engaging in therapy or the assessments 4. Currently having individual CBT (though previous experience of CBT is not an exclusion)
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Brief Core Schema Scale measured at 0 weeks, 8 weeks and 12 weeks | — |
Secondary
| Measure | Time frame |
|---|---|
| 1. Beck Anxiety Inventory measured at 0 weeks, 8 weeks, 12 weeks 2. Beck Depression Inventory measured at 0 weeks, 8 weeks, 12 weeks 3. Paranoid Thoughts Scale measured at 0 weeks, 8 weeks and 12 weeks 4. Psychotic Symptom Rating Scale - Delusions subscale measured at 0 weeks, 8 weeks and 12 weeks 5. The Robson Self-Concept Questionnaire measured at 0 weeks, 8 weeks, 12 weeks 6. Warwick-Edinburgh Mental Well-being scale measured at 0 weeks, 8 weeks, 12 weeks | — |
Countries
United Kingdom